Work

Biological Activity of Lenalidomide and Its Underlying Therapeutic Effects in Multiple Myeloma

Year: 2012
Type: article
Abstract: Lenalidomide is a synthetic compound derived by modifying the chemical structure of thalidomide. It belongs to the second generation of immunomodulatory drugs (IMiDs) and possesses pleiotropic properties. Even if lenalidomide has been shown to be active in the treatment of several hematologic malignancies, this review article is mostly focalized on its mode of action in multiple myeloma. The present paper is about the direct and indirect antitumor effects of lenalidomide on malignant plasmacells, bone marrow microenvironment, bone resorption and host's immune response. The molecular mechanisms and targets of lenalidomide remain largely unknown, but recent evidence shows cereblon (CRBN) as a possible mediator of its therapeutical effects.
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: gold
Estimated APC paid: $860
OpenAlex ID: W2163060468
FWCI: 4.543
Cites: 101
Cited by: 70
Related to: 9